Clinical Trial Update: Mitoxantrone Hydrochloride Liposome Injection, Cytarabine Combined With Venetoclax in the Treatment of R/R AML [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a combination of mitoxantrone hydrochloride liposome injection, cytarabine, and venetoclax for relapsed/refractory acute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myeloid Malignancy

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)
• Venetoclax (venetoclax)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy | Phase 2 | Status: RECRUITING